UNSPSC 51351515: Proligestone

This classification denotes a therapeutic progestin with the molecular formula C24H34O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 55772LJ01V, chemically known as 14,17-dihydroxypregn-4-ene-3,20-dione, cyclic acetal with propionaldehyde but generally known as proligestone, which bears US NIH Compound Identifier 71906. European Medicines Agency schedules Proligestone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10081MIG.

UNSPSC 51351515 Proligestone is a Commodity code naming a synthetic progestin used in veterinary medicine, primarily as a contraceptive and estrus-cycle management agent in companion animals. State and local governments procure this product almost exclusively through animal control agencies, municipal shelters, and county health departments operating spay-neuter programs and animal welfare services. The work involves purchasing pharmaceutical inventory for population management of stray and surrendered animals, typically as part of competitive bids for shelter medical supplies or through cooperative purchasing agreements with state veterinary pharmaceutical distributors. Issuing bodies are predominantly municipal animal control departments and county animal-services divisions, with occasional procurement by independent school districts maintaining animal science or veterinary technology education programs.

The recent opportunities block contains no posted solicitations for UNSPSC 51351515, indicating minimal current activity or public notice availability under this code. State and local procurement of proligestone occurs but does not generate high-volume or widely-publicized RFP or IFB activity; most purchases are consolidated into broader animal-shelter medical-supply contracts or cooperative-purchasing orders placed through existing vendor relationships rather than competitive solicitations tied to this specific code. The lack of recent opportunity records suggests the code sees episodic demand rather than continuous procurement cycles, typical for specialized veterinary pharmaceuticals where demand is driven by shelter census and spay-neuter program scheduling rather than standing purchasing requirements.